Clinical Trial Update: Cabazitaxel in Platinum Refractory Ovarian Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study of cabazitaxel in platinum-refractory ovarian cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Jevtana (cabazitaxel)

Snippet

Sponsor: Vejle Hospital | Conditions: Ovarian Cancer | Phase 2 | Status: TERMINATED